Literature DB >> 35813318

Erratum to miR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer.

.   

Abstract

[This corrects the article DOI: 10.21037/atm-21-6556.]. 2022 Annals of Translational Medicine. All rights reserved.

Entities:  

Year:  2022        PMID: 35813318      PMCID: PMC9263791          DOI: 10.21037/atm-2022-15

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


In the article entitled “MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer” (1), there are some errors. Firstly, the 7th author “Hao Zheng” should be removed from the authorship and Xian-Gui Hu’s email is incorrect. The authors regret the error due to a lack of communication before publication by listing Hao Zheng in the authorship without his consent. Therefore, the authors’ information should be corrected as follows: The authorship, affiliation and author contribution should be corrected as Liu Ouyang1#, Ren-Dong Liu2#, De-Qiao Lei3#, Qing-Chao Shang4#, Hui-Fen Li5, Xian-Gui Hu1, Gang Jin1 1Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China; 2Department of Hepatobiliary Surgery, General Hospital of Southern Theatre Command, Guangzhou, China; 3Department of General Surgery, General Hospital of Southern Theatre Command, Guangzhou, China; 4Department of Radiation Oncology, General Hospital of Southern Theatre Command, Guangzhou, China; 5Department of Hepatic Surgery & Interventional Radiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China #These authors contributed equally to this work. Contributions: (I) Conception and design: G Jin; (II) Administrative support: L Ouyang, RD Liu, DQ Lei, QC Shang; (III) Provision of study materials or patients: HF Li; (IV) Collection and assembly of data: L Ouyang; (V) Data analysis and interpretation: L Ouyang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Gang Jin; Xian-Gui Hu. Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200438, China. Email: jingang@smmu.edu.cn; hxiangui@126.com/huxg88@hotmail.com. Secondly, in the section of Methods-Real-time quantitative polymerase chain reaction (qRT-PCR), “miR-2053 expression” should be corrected to “miR-499a-5p expression”. Thirdly, in Table 1, column 1, rows 9 “Rectum” should be corrected to “head”; column 1, rows 10 “Colon” should be corrected to “body and Tail”. The authors confirmed the above errors did not affect either the results or the conclusions of the paper. Click here to view the updated version of the article.
  1 in total

1.  MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer.

Authors:  Liu Ouyang; Ren-Dong Liu; De-Qiao Lei; Qing-Chao Shang; Hui-Fen Li; Xian-Gui Hu; Hao Zheng; Gang Jin
Journal:  Ann Transl Med       Date:  2021-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.